1. Home
  2. IKNA vs REE Comparison

IKNA vs REE Comparison

Compare IKNA & REE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKNA
  • REE
  • Stock Information
  • Founded
  • IKNA 2016
  • REE 2011
  • Country
  • IKNA United States
  • REE Israel
  • Employees
  • IKNA N/A
  • REE N/A
  • Industry
  • IKNA Biotechnology: Pharmaceutical Preparations
  • REE Auto Manufacturing
  • Sector
  • IKNA Health Care
  • REE Consumer Discretionary
  • Exchange
  • IKNA Nasdaq
  • REE Nasdaq
  • Market Cap
  • IKNA 61.8M
  • REE 70.5M
  • IPO Year
  • IKNA 2021
  • REE N/A
  • Fundamental
  • Price
  • IKNA $1.13
  • REE $3.01
  • Analyst Decision
  • IKNA Buy
  • REE Strong Buy
  • Analyst Count
  • IKNA 2
  • REE 3
  • Target Price
  • IKNA $3.00
  • REE $12.50
  • AVG Volume (30 Days)
  • IKNA 96.4K
  • REE 90.1K
  • Earning Date
  • IKNA 05-08-2025
  • REE 05-29-2025
  • Dividend Yield
  • IKNA N/A
  • REE N/A
  • EPS Growth
  • IKNA N/A
  • REE N/A
  • EPS
  • IKNA N/A
  • REE N/A
  • Revenue
  • IKNA N/A
  • REE $626,000.00
  • Revenue This Year
  • IKNA N/A
  • REE N/A
  • Revenue Next Year
  • IKNA N/A
  • REE $18,744.14
  • P/E Ratio
  • IKNA N/A
  • REE N/A
  • Revenue Growth
  • IKNA N/A
  • REE N/A
  • 52 Week Low
  • IKNA $0.97
  • REE $2.31
  • 52 Week High
  • IKNA $1.94
  • REE $11.72
  • Technical
  • Relative Strength Index (RSI)
  • IKNA 43.57
  • REE 47.76
  • Support Level
  • IKNA $1.22
  • REE $2.68
  • Resistance Level
  • IKNA $1.29
  • REE $3.25
  • Average True Range (ATR)
  • IKNA 0.09
  • REE 0.25
  • MACD
  • IKNA -0.01
  • REE 0.12
  • Stochastic Oscillator
  • IKNA 23.33
  • REE 63.08

About IKNA Ikena Oncology Inc.

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.

About REE REE Automotive Ltd.

REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is developing REEcorner technology which packs critical vehicle components into a single compact module positioned between the chassis and the wheel as well as building commercial Electric Vehicles (EV) leveraging REEcorner technology. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.

Share on Social Networks: